Amendment to SubleaseSublease • August 1st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
This is an amendment (“Amendment”) to the Agreement. To the extent any provision of this Amendment conflicts with any of the provisions of the Agreement, the provisions of this Amendment shall govern. Capitalized terms but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Agreement, as applicable. Except for the amendments made hereby, the above referenced Agreement remains in full force and effect. This Amendment is effective as of April 19, 2019 (the “Amendment Effective Date”).
Toll Manufacturing and Service Agreement by and between bluebird bio, Inc. and APCETH Biopharma GmbH November 18, 2016And Service Agreement • August 1st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
INDICATES MATERIAL THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.Sublease • August 1st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS SUBLEASE (this “Sublease”), dated as of April 16, 2019 (the “Effective Date”), between AVENTIS INC., a Pennsylvania corporation, having an address at North American Legal Department, U.S. Corporate, 55 Corporate Drive, Mail Stop 55A-525A, Bridgewater, New Jersey 08807-0977 (“Lessor”) and BLUEBIRD BIO, INC., a Delaware corporation, having an address at 60 Binney Street, Cambridge, Massachusetts 02142, Attn: General Counsel (“Lessee”).
Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio, Inc. and SAFC Carlsbad, Inc. November 27, 2017Clinical and Commercial Supply Agreement • August 1st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Clinical and Commercial Supply Agreement (this “Agreement”), executed as of November 27, 2017 and effective as of January 1, 2018 (the “Effective Date”), is entered into by and between:
